XOMA Royalty Corporation

XOMAP | NASDAQ

Price Alert Chart Builder DCF Calculator

$24.98

$0 (0.00%)

At close: Jul 14, 2026, 9:30 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Dividends Profile

+0.00%

(1D)

Rating

Updated: May 21, 2026

54.5

Fundamentals Strong

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $301.34M

1D Range

24.98 24.98

52W Range

24.93 30

Valuation (TTM)

PE 15.14

PB 2.67

EV/EBITDA 6.55

Valuation (NTM)

Forward PE 24.76

Forward PEG -0.14

Price Target N/A

Cash Flow

FCF Yield 2.2%

SBC Adj. FCF Yield 0.9%

SBC Impact -59.0%

Margins

Gross Margin 94.3%

Operating Margin 18.1%

FCF Margin 24.2%

Growth (CAGR)

Revenue 3Y | 5Y 101.4% | -1.1%

Dil EPS 3Y | 5Y 439.5% | 11.9%

FCF 3Y | 5Y 202.4% | 8.1%

Returns

ROA 12.4%

ROE 32.4%

ROIC 1.9%

Financial Health

Net Debt

$10.27M

Current Ratio 3.59

Interest Coverage 0.37

Dividends

Div Yield 8.65%

Payout Ratio 130.7%

FCF Payout Ratio 83.3%

All Key Statistics

Loading financial charts...

Profile

XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States, Switzerland, the Asia Pacific, and Australia. It has a portfolio of economic rights to future potential mileston...

Sector Healthcare

Industry Medical - Pharmaceuticals

Employees 14

IPO Date Dec 15, 2020

Website www.xoma.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.